| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | TN7CUD1NGA |
| InChI Key | IBHOLSBDZMIPPT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C32H37N5O6 |
| Molecular Weight | 587.68 |
| AlogP | 4.47 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 127.18 |
| Molecular species | BASE |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 43.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Fibroblast growth factor receptor 1 inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase FGFR family
|
- | 0.71-5.8 | - | - | - | |
|
Secreted protein
|
- | 4.5 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3686884 |
| FDA SRS | TN7CUD1NGA |
| SureChEMBL | SCHEMBL15955142 |
| ZINC | ZINC000169711512 |